Copeptin has the potential to independently predict the development of pneumonia during hospitalization, as well as reliably provide an estimation of the functional outcome at 3- months poststroke. However, the added prognostic value of copeptin was found to be limited, while no correlation was demonstrated between plasma copeptin level and mortality. Here, AVP is linked to pneumonia.